University of Helsinki
University of Helsinki is one of the 25 Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Professor Mikael Knip, the TrialNet team at the University of Helsinki is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
Minna Hirvasniemi, RN
If you have a relative with T1D, you may be eligible for risk screening that can detect the early stages of T1D years before symptoms appear. More
If you are diagnosed with T1D while participating in one of our prevention studies, we’re still here for you. You can continue to receive personal monitoring while helping us learn more. More